PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2019 | 68 | 1 |

Tytuł artykułu

Comparison of performance characteristics of DxN VERIS system versus Qiagen PCR for HBV genotype D and HCV genotype 1b quantification

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
The Beckman Coulter DxN VERIS system is a fully automated, closed molecular diagnostic instrument for viral load quantification of hepatitis B virus and hepatitis C virus. In this study, the analytical performance of this new system was compared to routine diagnostic Qiagen PCR kit by using the same clinical samples. The DxN VERIS system demonstrated a high analytical performance. The DxN VERIS allows random access, which means that samples can be uploaded straight on to the system at any time; so, it provides an improvement of workflow, staff productivity and allows faster turn-around of viral load results.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

68

Numer

1

Opis fizyczny

p.139-143,fig.,ref.

Twórcy

autor
  • PCR Unit, Clinical Laboratory, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
autor
  • Research Center of Experimental Health Sciences, Near East University, Nicosia, Northern Cyprus
  • Department of Medical Microbiology, Faculty of Medicine, Near East University, Nicosia, Northern Cyprus
autor
  • Research Center of Experimental Health Sciences, Near East University, Nicosia, Northern Cyprus
  • Department of Medical Microbiology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey

Bibliografia

  • Akhan S, Aynioglu A, Cagatay A, Gonen I, Gunal O, Kaynar T, Kuruuzum Z, Sayan M, Tunca B, Tulek N, et al. [Management of chronic hepatitis B virus infection: A consensus report of the study group for viral hepatitis of the Turkish society of clinical microbiology and infectious diseases]. (in Turkish). Klimik Dergisi/Klimik J. 2015;27(1):2–18. doi:10.5152/kd.2014.26
  • Braun P, Drago M, Fanti D, Fleury H, Hofmann J, Izopet J, Kühn S, Lombardi A, Micheli V, Sauné K, et al. A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS® TaqMan® HCV Test and RealTime HCV Assay. J Clin Virol. 2017;90:18–25. doi:10.1016/j.jcv.2017.03.006 Medline
  • Caccamo G, Saffioti F, Raimondo G. Hepatitis B virus and hepatitis C virus dual infection.World J Gastroenterol. 2014;20(40):14559–14567. doi:10.3748/wjg.v20.i40.14559 Medline
  • Easterbrook PJ, Roberts T, Sands A, Peeling R. Diagnosis of viral hepatitis.Curr Opin HIV AIDS. 2017;12(3):302–314.doi:10.1097/COH.0000000000000370 Medline
  • EASL [European Association for the Study of the Liver]. EASL recommendations on treatment of hepatitis C 2016. J Hepatol. 2017a;66(1):153–194. doi:10.1016/j.jhep.2016.09.001
  • EASL [European Association for the Study of the Liver]. EASL 2017clinical practice guidelines on the management of hepatitis B virusinfection. J Hepatol. 2017b;67(2):370–398. doi:10.1016/j.jhep.2017.03.021
  • Karatas E, Erensoy S, Akarca US, Sertöz R. [Analysis of hepatitis B virus (HBV) preS1, preS2 and S gene regions from patient groups infected with HBV genotype D] (in Turkish). Mikrobiyol Bul. 2018;52(1):23–34. Medline
  • Micheli V, Lombardi A, Mancon A, Mileto D, Zanchetta N, Magni CF, Milazzo L, Angeli E, Gubertini G, Galli M, et al.DxN VERIS system for HCV viral load monitoring in the era of second wave direct-acting antiviral agents.J Hepatol. 2016;64(2):S627.doi:10.1016/S0168-8278(16)01165-X
  • Park J, Cho H, Choi SJ, Lee GD, Sin SH, Ryu JH, Park HS, Lee H, Kim Y, Oh EJ. Performance evaluation of the Beckman Coulter DxN VERIS hepatitis B virus (HBV) assay in comparison with the Abbott real time HBV assay.Ann Lab Med. 2019;39(1):86–90. doi:10.3343/alm.2019.39.1.86 Medline
  • Portilho MM, Baptista ML, da Silva M, de Sousa PSF, Lewis-Ximenez LL, Lampe E, Villar LM. Usefulness of in-house PCR methods for hepatitis B virus DNA detection. J Virol Methods. 2015;223:40–44. doi:10.1016/j.jviromet.2015.07.010 Medline
  • Sauné K, Abravanel F, Haslé C, Boineau J, Mengelle C, Izopet J. Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA.J Clin Virol. 2016;84:7–11.doi:10.1016/j.jcv.2016.09.003 Medline
  • Singh MP, Galhotra S, Saigal K, Kumar A, Ratho RK. Quantitative nucleic acid amplification methods and their implications in clinical virology. Int J Appl Basic Med Res. 2017;7(1):3–9.doi:10.4103/2229-516X.198498Medline
  • Williams JA, Rodriguez J, Wang Z, Lykstad K, Donvito G, Fung J, Howell C, Colinayo VV, Gustafson E, Scholl T. Quantitative detection of hepatitis B Virus (HBV) on the VERIS MDx System. In:24th European Congress of Clinical Microbiology and Infectious Diseases, 10–13 May 2014, Barcelona, Spain. [Internet] [cited 2018 September 14];Poster Presentation:P1422. Available from:https://www.escmid.org/escmid_publications/escmid_elibrary/material/?mid=16949
  • Wu B, Xiao F, Li P, Du Y, Lin J, Ming K, Chen B, Lei X, Xu B, Liu D. Ultrasensitive detection of serum hepatitis B virus by coupling ultra-filtration DNA extraction with real-time PCR. PLoS One. 2017; 12(2):e0170290.doi:10.1371/journal.pone.0170290Medline

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-dd0ae9f9-3592-4c30-8950-e753654af375
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.